Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1350.20
11.70 (0.87%) Dr Reddys Laboratories informs about press release
Date: 08-02-2016Dr Reddys Laboratories has informed about a press release dated February 08, 2016 titled ‘Promius Pharma? Receives FDA Approval for Sernivo (betamethasone dipropionate) Spray, 0.05%’.
The above information is a part of company’s filings submitted to BSE.